Autostimulation in Vagus Nerve Stimulator Treatment: Modulating Neuromodulation

Area of Science:

• Neurology
• Biomedical Engineering
• Epilepsy Research

Background:

• Vagus nerve stimulation (VNS) is an established epilepsy treatment using normal or magnet modes.
• A new VNS model (106 AspireSR®) introduces automatic stimulation (AutoStim).

Purpose of the Study:

• To evaluate the impact of AutoStim on seizure frequency.
• To assess the energy consumption of the new VNS model with AutoStim.

Main Methods:

• Retrospective analysis of 14 epilepsy patients who transitioned from older VNS models (102/103) to model 106.
• Calculation of theoretical daily electrical charge (VNS dose) for both old and new models.
• Evaluation of seizure diaries and seizure severity data over a mean follow-up of 18.1 months.

Main Results:

• Model 106 significantly reduced the total daily VNS charge (p = 0.001).
• AutoStim reduced average daily charge to 142.56 mC compared to 321.09 mC without it.
• 36% of patients experienced >50% seizure reduction, and 18% noted reduced seizure severity with AutoStim.

Conclusions:

• VNS with AutoStim effectively maintains seizure control with substantially lower energy usage.
• The AspireSR® model demonstrates potential for improved seizure control compared to previous VNS devices.
• Optimizing VNS parameters, like duty cycle, is crucial for maximizing therapeutic benefits.